{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:05:31Z","timestamp":1790723131988,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012270","name":"Shaanxi Key Science and Technology Innovation Team Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jormas.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:46:43Z","timestamp":1576648003000},"page":"264-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"121","author":[{"given":"J.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0255","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jormas.2019.12.003_bib0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-017-0390-4","article-title":"Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update","volume":"24","author":"Chen","year":"2017","journal-title":"J Biomed Sci"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.oooo.2018.02.004","article-title":"Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review","volume":"125","author":"Martos-Fernandez","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy: an initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.jormas.2019.12.003_bib0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.jormas.2019.12.003_bib0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"11","key":"10.1016\/j.jormas.2019.12.003_bib0285","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.joms.2017.04.017","article-title":"Preventive effect of phosphodiesterase inhibitor pentoxifylline against medication-related osteonecrosis of the jaw: an animal study","volume":"75","author":"Yalcin-Ulker","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.jormas.2019.12.003_bib0290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jormas.2017.06.012","article-title":"and perspectives of its treatment","volume":"118","author":"Voss","year":"2017","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2019.12.003_bib0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jormas.2017.12.009","article-title":"Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review","volume":"119","author":"Compain","year":"2018","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"9","key":"10.1016\/j.jormas.2019.12.003_bib0300","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jcms.2015.07.035","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results","volume":"43","author":"Reich","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0305","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3892\/mmr.2016.5834","article-title":"Zoledronate induces autophagic cell death in human umbilical vein endothelial cells via Beclin-1 dependent pathway activation","volume":"14","author":"Lu","year":"2016","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0310","first-page":"2879","article-title":"Zoledronate suppresses VEGFinduced capillary tube formation and inhibits expression of interferoninduced transmembrane protein1 in human umbilical vein endothelial cells","volume":"41","author":"Kim","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jormas.2019.12.003_bib0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.actbio.2017.02.040","article-title":"Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study","volume":"54","author":"Forte","year":"2017","journal-title":"Acta Biomater"},{"issue":"9","key":"10.1016\/j.jormas.2019.12.003_bib0320","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00784-018-2385-2","article-title":"Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat","volume":"22","author":"Kun-Darbois","year":"2018","journal-title":"Clin Oral Investig"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0325","first-page":"1793","article-title":"Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease","volume":"33","author":"Sivolella","year":"2013","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.jormas.2019.12.003_bib0330","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral Maxillofacial S. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.jormas.2019.12.003_bib0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7150\/ijms.22627","article-title":"Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"15","author":"Manzano-Moreno","year":"2018","journal-title":"Int J Med Sci"},{"issue":"7","key":"10.1016\/j.jormas.2019.12.003_bib0340","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/SCS.0000000000003617","article-title":"Would be prophylactic administrations of low concentration of alendronate an alternative for improving the craniofacial bone repair?. A preliminary study focused in the period of cellular differentiation and tissue organization","volume":"28","author":"Gohringer","year":"2017","journal-title":"J Craniofac Surg"},{"issue":"2","key":"10.1016\/j.jormas.2019.12.003_bib0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.2985","article-title":"IL-36 induces bisphosphonate-related osteonecrosis of the jaw-like lesions in mice by inhibiting tgf-beta-mediated collagen expression","volume":"32","author":"Kim","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jormas.2019.12.003_bib0350","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1038\/s41598-019-43798-z","article-title":"Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid","volume":"9","author":"Steller","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jormas.2019.12.003_bib0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcms.2018.10.017","article-title":"Impact of incubation method on the release of growth factors in non-Ca(2+)-activated PRP, Ca(2+)-activated PRP, PRF and A-PRF","volume":"47","author":"Steller","year":"2019","journal-title":"J. Craniomaxillofac Surg"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0360","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00784-017-2292-y","article-title":"Prolonged use of alendronate alters the biology of cranial repair in estrogen-deficient rats\u2019 associated simultaneous immunohistochemical expression of TGF-beta1+, alpha-ER+, and BMPR1B","volume":"22","author":"Giovanini","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jormas.2019.12.003_bib0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1479-5876-9-102","article-title":"Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFbeta1-signaling and increased Galectin-3 expression: a histological study on biopsies","volume":"9","author":"Wehrhan","year":"2011","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.jormas.2019.12.003_bib0370","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1002\/jcb.27209","article-title":"Inhibition of transforming growth factor-beta signaling pathway enhances the osteogenic differentiation of unrestricted somatic stem cells","volume":"119","author":"Hedayati","year":"2018","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.jormas.2019.12.003_bib0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41368-018-0021-2","article-title":"Bone-conditioned medium contributes to initiation and progression of osteogenesis by exhibiting synergistic TGF-beta1\/BMP-2 activity","volume":"10","author":"Asparuhova","year":"2018","journal-title":"Int J Oral Sci"},{"issue":"8","key":"10.1016\/j.jormas.2019.12.003_bib0380","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jn\/nxy097","article-title":"Lactoferrin Promotes Osteogenesis through TGF-beta Receptor I.I Binding in Osteoblasts and Activation of Canonical TGF-beta Signaling in MC3T3-E1 Cells and C57BL\/6J Mice","volume":"148","author":"Li","year":"2018","journal-title":"J Nutr"},{"key":"10.1016\/j.jormas.2019.12.003_bib0385","article-title":"High-dose tgf-beta1 impairs mesenchymal stem cell-mediated bone regeneration via bmp2 inhibition","author":"Xu","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0390","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0022034517691507","article-title":"Role of bone marrow stromal cells in impaired bone repair from BRONJ osseous lesions","volume":"96","author":"He","year":"2017","journal-title":"J Dent Res"},{"key":"10.1016\/j.jormas.2019.12.003_bib0395","doi-asserted-by":"crossref","first-page":"36129","DOI":"10.1038\/srep36129","article-title":"Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity","volume":"7","author":"Gong","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jormas.2019.12.003_bib0400","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J Dent Res"},{"issue":"1","key":"10.1016\/j.jormas.2019.12.003_bib0405","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jop.12646","article-title":"Denosumab-related osteonecrosis of the jaw: A retrospective study","volume":"47","author":"Egloff-Juras","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jormas.2019.12.003_bib0410","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.jormas.2019.12.003_bib0415","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2016.10.012","article-title":"Possible pathogenic engagement of soluble Semaphorin 4D produced by gammadeltaT cells in medication-related osteonecrosis of the jaw (MRONJ)","volume":"480","author":"Movila","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jormas.2019.12.003_bib0420","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1096\/fj.201801791RR","article-title":"Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw","volume":"33","author":"Zhu","year":"2019","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jormas.2019.12.003_bib0425","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijom.2011.12.016","article-title":"Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease","volume":"41","author":"Marx","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.jormas.2019.12.003_bib0430","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3109\/00016357.2013.765592","article-title":"Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans","volume":"71","author":"Carmagnola","year":"2013","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.jormas.2019.12.003_bib0435","first-page":"1279280","article-title":"Pentoxifylline regulates plasminogen activator inhibitor-1 expression protein kinase A phosphorylation in radiation-induced lung fibrosis","volume":"2017","author":"Lee","year":"2017","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.jormas.2019.12.003_bib0440","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/10641963.2017.1291662","article-title":"Effects of pentoxifylline on hemodynamic, hemorheological, and microcirculatory parameters in young SHRs during arterial hypertension development","volume":"39","author":"Plotnikov","year":"2017","journal-title":"Clin Exp Hypertens"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0445","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/tbj.13044","article-title":"Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer","volume":"24","author":"Kaidar-Person","year":"2018","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.jormas.2019.12.003_bib0450","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1667\/RR14926.1","article-title":"Development and characterization of an in vitro model for radiation-induced fibrosis","volume":"189","author":"Kumar","year":"2018","journal-title":"Radiat Res"},{"issue":"6","key":"10.1016\/j.jormas.2019.12.003_bib0455","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/C8BM01691G","article-title":"Relating the blood-thinning effect of pentoxifylline to the reduction in the elastic modulus of human red blood cells: an in vivo study","volume":"7","author":"Aifantis","year":"2019","journal-title":"Biomater Sci"},{"issue":"9","key":"10.1016\/j.jormas.2019.12.003_bib0460","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1111\/jcmm.14498","article-title":"The Akt\/FoxO\/p27(Kip1) axis contributes to the anti-proliferation of pentoxifylline in hypertrophic scars","volume":"23","author":"Yang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jormas.2019.12.003_bib0465","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-019-05600-8","article-title":"Effects of pentoxifylline and tocopherol on a rat-irradiated jaw model using micro-CT cortical bone analysis","author":"Nguyen","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0470","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/pr.2017.6","article-title":"Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns","volume":"81","author":"Speer","year":"2017","journal-title":"Pediatr Res"},{"issue":"12.","key":"10.1016\/j.jormas.2019.12.003_bib0475","article-title":"Pentoxifylline Alone or in Combination with Gentamicin or Vancomycin Inhibits Live Microbe-Induced Proinflammatory Cytokine Production in Human Cord Blood and Cord Blood Monocytes In Vitro","volume":"62","author":"Speer","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jormas.2019.12.003_bib0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bone.2019.03.010","article-title":"Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone","volume":"123","author":"Pal","year":"2019","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jormas.2019.12.003_bib0485","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S8756-3282(02)00839-6","article-title":"phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells","volume":"31","author":"Tsutsumimoto","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2019.12.003_bib0490","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ecoenv.2019.05.001","article-title":"Monitoring soil biological properties during the restoration of a phosphate mine under different tree species and plantation types","volume":"180","author":"Gu","year":"2019","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"10.1016\/j.jormas.2019.12.003_bib0495","first-page":"36","article-title":"phossy jaw, and bisphosphonate-related osteonecrosis of the jaw","volume":"102","author":"Lewis","year":"2011","journal-title":"J Okla Dent Assoc"},{"issue":"11","key":"10.1016\/j.jormas.2019.12.003_bib0500","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.joms.2007.11.006","article-title":"Uncovering the cause of \u201cphossy jaw\u201d Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed","volume":"66","author":"Marx","year":"2008","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785519302897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785519302897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:39:11Z","timestamp":1778895551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785519302897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2468785519302897"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2019.12.003","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology, Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}